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Examining Escherichia coli glycolytic 
pathways, catabolite repression, and metabolite 
channeling using Δpfk mutants
Whitney D. Hollinshead1, Sarah Rodriguez2,3, Hector Garcia Martin3,4, George Wang3,4, Edward E. K. Baidoo3,4, 
Kenneth L. Sale3,4, Jay D. Keasling3,4,5,6,7,8, Aindrila Mukhopadhyay3,4* and Yinjie J. Tang1* 
Abstract 
Background: Glycolysis breakdowns glucose into essential building blocks and ATP/NAD(P)H for the cell, occupying 
a central role in its growth and bio-production. Among glycolytic pathways, the Entner Doudoroff pathway (EDP) is a 
more thermodynamically favorable pathway with fewer enzymatic steps than either the Embden–Meyerhof–Parnas 
pathway (EMPP) or the oxidative pentose phosphate pathway (OPPP). However, Escherichia coli do not use their native 
EDP for glucose metabolism.
Results: Overexpression of edd and eda in E. coli to enhance EDP activity resulted in only a small shift in the flux 
directed through the EDP (~20 % of glycolysis flux). Disrupting the EMPP by phosphofructokinase I (pfkA) knockout 
increased flux through OPPP (~60 % of glycolysis flux) and the native EDP (~14 % of glycolysis flux), while overexpress-
ing edd and eda in this ΔpfkA mutant directed ~70 % of glycolytic flux through the EDP. The downregulation of EMPP 
via the pfkA deletion significantly decreased the growth rate, while EDP overexpression in the ΔpfkA mutant failed 
to improve its growth rates due to metabolic burden. However, the reorganization of E. coli glycolytic strategies did 
reduce glucose catabolite repression. The ΔpfkA mutant in glucose medium was able to cometabolize acetate via the 
citric acid cycle and gluconeogenesis, while EDP overexpression in the ΔpfkA mutant repressed acetate flux toward 
gluconeogenesis. Moreover, 13C-pulse experiments in the ΔpfkA mutants showed unsequential labeling dynamics in 
glycolysis intermediates, possibly suggesting metabolite channeling (metabolites in glycolysis are pass from enzyme 
to enzyme without fully equilibrating within the cytosol medium).
Conclusions: We engineered E. coli to redistribute its native glycolytic flux. The replacement of EMPP by EDP did 
not improve E. coli glucose utilization or biomass growth, but alleviated catabolite repression. More importantly, our 
results supported the hypothesis of channeling in the glycolytic pathways, a potentially overlooked mechanism for 
regulating glucose catabolism and coutilization of other substrates. The presence of channeling in native pathways, if 
proven true, would affect synthetic biology applications and metabolic modeling.
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Background
Escherichia coli have three native glycolytic pathways: 
EMPP, EDP, and OPPP. The EMPP employs ten enzy-
matic steps to yield two pyruvates, two ATP, and two 
NADH per glucose molecule [1], while OPPP serves 
as an oxidation route for NADPH synthesis. In E. coli, 
glucose metabolism mainly relies on the EMPP and the 
OPPP, while the EDP primarily remains inactive except 
during growth with gluconate [2]. The EDP utilizes 
only five enzymes to produce one pyruvate, one glycer-
aldehyde-3-phosphate, and one NADPH per glucose 
molecule (Fig. 1). With further conversion of glyceralde-
hyde-3-phosphate via the lower EMPP, the two pathways 
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(EDP and EMPP) result in the same net production of 
pyruvate. However, the EMPP contains thermodynamic 
bottlenecks, comprising of fructose 1,6-bisphosphate 
aldolase and triose-phosphate isomerase. The EDP avoids 
both these unfavorable reactions (at the expense of ATP 
yield), and requires substantially less enzymatic protein 
than the EMPP [3]. Its end-products (glyceraldehyde 
3-phosphate and pyruvate) are precursors of the non-
mevalonate pathway, and thus, EDP upregulation has 
been proven to improve the yields of isoprenoids [4–6]. 
In addition, the EDP may also alleviate oxidative stress [7, 
8] and improve NADPH generation without the loss of 
carbon (i.e., CO2) [9].
The EDP relies on two unique enzymes phosphoglu-
conate dehydratase (edd) and 2-dehydro-3-deoxyphos-
phogluconate aldolase (eda), which are separate from the 
enzymes shared with the EMPP and OPPP. In wild-type 
(WT)  E. coli, EDP flux is  negligible. Δpgi (G6P→F6P, 
encoding glucose-6-phosphate isomerase), Δpfk 
(F6P→FBP, encoding phosphofructokinase), or over-
expression of OPPP may redirect glycolytic fluxes and 
increase EDP activity [10, 11]. Δpgi mutant has measure-
able EDP flux (up to ~15 % of glycolysis), but grew and 
consumed glucose more slowly than the WT strain. Δpgi 
mutant may recover its growth rate by either increasing 
acetate overflow or activating the glyoxylate shunt after 
adaptive evolution [12]. Moreover, some bacterial species 
with exclusive EDP activity (e.g., Rhodococcus opacus) 
can coutilize glucose with other substrates [13]. Thus, we 
were curious if the presence of a highly active EDP could 
alleviate E. coli glucose catabolite repression and promote 
cell growth. To reorganize the glycolytic pathways, we 
engineered and characterized ΔpfkA mutants (deletion 
of phosphofructokinase I, important in the regulation 
Fig. 1 Redistribution of fluxes between the three primary glucose catabolic pathways: EMPP (red), EDP (blue), and OPPP (orange) via the knockout 
of pfkA and overexpression of EDP genes (edd and eda). Table on the right presents the estimated flux ratio between the three pathways for each 
strain. The dashed arrows represent a possible interference (unannotated) source from glycogen metabolism [27]
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of glycolysis-gluconeogenesis, Fig.  1). Through growth 
experiments and 13C-labeling, we elucidated E. coli physi-
ological changes and its capability for simultaneous utili-
zation of carbon substrates. Finally, ΔpfkA mutants also 
allowed us to evaluate the hypothesis of the existence of 
metabolite channeling in glycolytic pathways [14].
Results
Overexpression of EDP in E. coli
Overexpressing edd and eda in the wild-type (WT) strain 
reduced the flux (~20  %) through EMPP and OPPP. 
Despite the increased EDP activity, the growth rate of 
the EDP overexpressing strain decreased by ~30 % com-
pared to WT (Table  1). To confirm the tradeoff from 
metabolic burdens imposed by antibiotics and plasmid/
protein expression, we replaced EDP genes with the gene 
encoding for yellow fluorescent protein (YFP). The YFP-
expressing strain had a similar reduced growth. A recent 
study found that the insertion of EDP (pgi, zwf, pgl, 
edd, eda from Z. mobilis) into E. coli chromosome also 
repressed the growth of the engineered strain [4].
To further improve EDP flux, the Keio collection ΔpfkA 
(phosphofructokinase I, F6P→FBP) mutant was used 
[15]. The phosphofructokinase has two isoenzymes (pfkA 
and pfkB) with pfkA as the primary enzyme responsi-
ble for the conversion of F6P to FBP [16]. 13C-finger-
printing revealed that the ΔpfkA mutant (JW3887) 
distributed glucose flux through the OPPP (~62  %), the 
EDP (~14  %) and the EMPP (~24  %) (Fig.  1). The pfkA 
knockout increased cell lag phase, and reduced both cell 
growth rate and acetate overflow (Additional file 1: Fig-
ure S1). This is because the glycolytic flux reorganiza-
tion can cause metabolic burdens, cofactor imbalances, 
and reduced carbon yield due to CO2 loss from the 
high OPPP flux [17]. Overexpressing EDP in the ΔpfkA 
mutant (resulting in strain WH04) raised the EDP flux 
to ~72 % and reduced the EMPP flux to ~18 % (Fig. 1). 
WH04 grew much faster than WH02 (the ∆pfkA mutant 
with YFP overexpression) (Table  1), demonstrating a 
beneficial impact of EDP in the absence of EMPP.
Removal of glucose, carbon catabolite repression
Lignocellulose hydrolysate contains glucose, xylose, and 
acetate. However, carbon catabolite repression (CCR) 
inhibits hosts from consuming diverse substrates simul-
taneously (i.e., E. coli mainly consumes glucose first in a 
glucose/xylose medium). The CCR is often explained by 
glucose inhibition on the synthesis of enzymes involved 
in catabolism of other carbon sources, while recent stud-
ies suggest that the presence of subpopulations within E. 
coli cultures can have different carbon utilization hierar-
chies [18, 19]. To investigate glucose catabolite repres-
sion, we grew the strains with a mixed carbon source 
of 10  g/L of glucose and 6  g/L of xylose, and measured 
the consumption of the two sugars (Fig.  2a, b). The 
ΔpfkA mutant (JW3887) simultaneously consumed glu-
cose and xylose, and xylose coutilization nearly doubled 
the growth rate compared to its glucose-only culture 
(Fig. 2a). WH04 can also uptake xylose with glucose, and 
xylose addition reduced the strain’s lag phase (Fig.  2b). 
Moreover, the assimilation of xylose into biomass was 
determined through 13C-experiments (cultures fed with 
13C6-glucose and unlabeled xylose). The fraction of xylose 
incorporated into proteinogenic amino acids during 
the exponential phase was measured (Fig.  2c). For both 
JW3887 and WH04, the xylose incorporation was ~50 % 
(Fig. 2c), much higher utilization than in the WT strain. 
Therefore, the removal of one pivotal EMP enzyme, 
phosphofructokinase I, alleviated glucose catabolite 
repression.
Acetate, another common component in lignocellulosic 
hydrolysate, has to be metabolized through gluconeogen-
esis [20]. ΔpfkA is expected to alleviate the EMPP repres-
sion on gluconeogenesis, and improve the coutilization of 
Table 1 Strains/plasmids used
Plasmids/strains Description Maximal growth 
rate (h−1)
JBEI
ICE
codes
Source
Plasmids
 pBbE5c-YFP Backbone vector expressing YFP – – [48]
 pEDW Derived from pBbE5c-YFP with gene replaced by edd and eda – – This study
Strains
 BW25113 Keio collection WT(rrnB3 ∆lacZ4787 hsdR514 ∆araBAD567 ∆rhaBAD568 rph-1) 0.78 ± 0.02 – [15]
 JW3887 BW25113 ∆pfkA 0.18 ± 0.02 –
 WH01 BW25113 (pBbE5c-YFP) 0.56 ± 0.07 JBEI-14575 This study
 WH02 JW3887 (pBbE5c-YFP) 0.13 ± 0.01 JBEI-14585 This study
 WH03 BW25113 (pEDW) 0.49 ± 0.02 JBEI-11465 This study
 WH04 JW3887 (pEDW) 0.18 ± 0.01 JBEI-11468 This study
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glucose and acetate. To test this hypothesis, the mutants 
(JW3887 and WH04) were grown with 10 g/L of glucose 
and supplemented with 6  g/L of sodium acetate during 
the early exponential phase (Fig. 3a–c). Although acetate 
may interfere with intracellular pH and hinder E. coli 
growth [21, 22], JW3887 was able to coutilize acetate 
with little effect on its growth. Acetate incorporation into 
biomass measured via cultures with unlabeled glucose 
and fully labeled acetate revealed that the mutant utilized 
acetate for biomass synthesis with enrichment of 13C into 
TCA and glycolysis-derived proteinogenic amino acids 
(Fig. 3d). In contrast, the glycolytic amino acids: Ala, Phe, 
and Ser, were unlabeled in WT under similar mixed car-
bon cultures, these amino acids being derived from PYR, 
PEP, and  3PG, respectively. Therefore, ΔpfkA (JW3887) 
could coutilize acetate to generate TCA cycle metabolites 
and glycolytic intermediates via upregulation of glucone-
ogenesis. However, introduction of EDP into the ΔpfkA 
mutant inhibited gluconeogenesis, as revealed with a lack 
of 13C Ala/Phe/Ser in WH04 biomass (Fig. 3d).
Dynamic labeling pattern for sugar phosphates in ΔpfkA 
mutants
We grew WT and the ΔpfkA mutants (WH04 and 
JW3887) with unlabeled glucose into the mid-exponen-
tial growth phase, and then, we added uniformly 13C6-
labeled glucose into the cultures. The resulting kinetics of 
13C-labeling incorporation in key metabolites was exam-
ined. The WT demonstrated very fast metabolite turno-
ver, such that most metabolites’ labeling reached isotopic 
steady state in 15 s (Fig. 4a and Additional file 2: Fig. S2). 
This observation is consistent with the rapid EMPP turn-
over rates previously reported [23]. In contrast, WH04 
had lower rates of labeling incorporation. Interestingly, 
G6P and 6PG appeared to be labeled slower than their 
downstream metabolites (3PG and PEP) (Fig.  4b, Addi-
tional file 3: Fig. S3). Similarly, the 13C-pulse experiment 
for JW3887 also revealed that 3PG and R5P reached high 
isotopic ratios more quickly than their higher pathway 
metabolites (G6P and 6PG), revealing unusual labeling 
patterns in glycolytic intermediates (Additional file 4: Fig. 
S4).
The unsequential 13C labeling patterns for glycolysis 
intermediates in ΔpfkA mutants could be explained by 
metabolite channeling (Fig.  5a): intermediates in meta-
bolic pathways are passed from enzyme to enzyme with-
out equilibration within the cellular medium [24]. For 
example, a large unlabeled metabolite pool formed out-
side of the ‘channel’ could dilute the labeled metabolite 
concentration, resulting in a slow labeling incorporation 
of the bulk metabolite, as measured by LC–MS methods. 
The downstream metabolites, however, retain their fast 
rates with their production primarily from the metabo-
lite pool within the ‘channel’. In a previous study, in vivo 
evidence discovered that EMPP intermediates are mainly 
concentrated within a ‘channel’ with minimal mixing 
with the cytoplasmic pool in E. coli [14]. In  vivo stud-
ies in eukaryotes and in  vitro studies also suggest that 
EMPP and OPPP metabolites (e.g., 6PG) are highly chan-
neled [25, 26]. In this study, disruption of EMPP chan-
nel by the knockout of pfkA caused a bottleneck in the 
conversion of F6P to FBP, which likely allowed hexose6P 
metabolites to accumulate within the cytosol. LC–MS 
peak abundances and isotopomer ratio analysis (Fig. 4c, 
Fig. 2 Glucose and xylose coutilization (n = 2). Profile of growth 
(open square), acetate production (star), and consumption of glucose 
(open circle) and xylose (open triangle) in mutant strains: a ∆pfkA 
mutant (JW3887) and b WH04 grown with glucose and xylose. OD600 
of cultures grown solely with glucose are also shown (closed circles).  
c 13C isotopic labeling tracing in cultivations fed 10 g/L of 13C6-glu-
cose and 6 g/L of unlabeled xylose. Xylose contribution (fraction of 
12C) in proteinogenic amino acids is graphed for the three strains (2 % 
isotopic measurement errors were applied)
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d) further confirmed that ∆pfkA (JW3887) and WH04 
had larger G6P and 6PG pool sizes than those in the 
WT. During 13C-pulse experiments, the unlabeled G6P 
and 6PG amassed in the cytosol could significantly slow 
the measured labeling of bulk hexose6P, causing 13C to 
appear more gradually than in their downstream metab-
olites (3PG and PEP). There could be other reasons for 
the observed labeling patterns in ∆pfkA mutants, such as 
activation of unknown pathways associated with glycoly-
sis (e.g., Δedd surprisingly increases glycogen accumula-
tion [27]), experimental artifacts during 13C-metabolite 
sampling/extraction or heterogenity due to different cell 
sub-populations within the mutant cultures. However, 
channeling is a logical explanation given the labeling pat-
tern difference between the WT and Δpfk mutants for 
only certain intermediates.
Fluxome response to changes in glycolytic pathway 
utilization
Flux balance analysis (FBA) was used to predict growth 
and flux distribution under different glycolytic pathways 
and carbon substrates [28]. Using the measured glyco-
lytic flux ratios, substrate utilization, and acetate produc-
tion as constraints, we performed FBA simulations on 
the mutant strains using maximal biomass growth as the 
objective function (Fig. 6a, b). FBA-predicted growth rate 
of WH04 agreed with the experimentally measured the 
glucose-based growth rate, while xylose and acetate co-
utilization models show certain discrepanies. The meas-
ured growth rates of JW3887 were  generally below the 
growth rates predicted by FBA (Fig.  6c). The knockout 
of pfkA may have unknown effects that cause a subopti-
mal metabolism for biomass synthesis. Unlike the WT 
strain, FBA predicted that ΔpfkA mutant and WH04 
upregulated the glyoxylate shunt and maintained low 
activity of anaplerotic pathways for glucose metabolism 
(Fig. 6a). Compared to WT, the absolute fluxes of energy 
production (ATP, NADH, and NADPH) rate in mutants 
were reduced (Fig.  6b). FBA improved our overview of 
the central metabolic responses to our glycolysis flux 
reorganization.
Discussion
Glycolytic pathways hold considerable control over car-
bon utilization and biosynthetic efficiency. The knowl-
edge of their regulation is crucial for designing optimal 
microbial production strains. For example, the desire 
to use cheap cellulosic feedstock has prompted meta-
bolic engineers to develop microbial hosts that utilize 
both 6- and 5-carbon sugars, simultaneously [29, 30]. 
However, carbon catabolite repression (CCR) prevents 
the simultaneous consumption of other carbon sources. 
Fig. 3 Glucose and acetate coutilization (n = 2). The growth (open square) and substrate consumption (glucose, open circle; acetate, open triangle) 
in mutant strains initially fed 10 g/L of glucose then supplemented with 6 g/L of sodium acetate (denoted in figure): a ∆pfkA (JW3887) and b WH04. 
OD600 of cultures grown solely with 10 g/L of glucose are also included (closed circles). c Maximal growth rate of WT, JW3887, and WH04 in cultures 
supplemented with 6 g/L of sodium acetate during early exponential phase (black bar). Control cultivations (no acetate; white bar) were supple-
mented with 6 g/L of sodium chloride to normalize for ion effects. d 13C tracing in cultivations fed 10 g/L of unlabeled glucose and 6 g/L of fully 
labeled 13C2-acetate. Acetate contribution (
13C fraction) in proteinogenic amino acids are shown for the three strains
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CCR is believed to act in E. coli by preferentially directing 
resources to consume glucose more efficiently by regulat-
ing its sugar transporters and carbon degradation path-
ways [31]. Approaches such as adaptive evolution and 
overexpression of xylose transport and catabolic genes 
have been tested to minimize CCR [29]. The knockout 
of phosphoenolpyruvate-dependent glucose phospho-
transferase system (PTS, the primary transport system 
for glucose) has also been shown to be an effective way 
to enable glucose and xylose coutilization [32–35], but 
has a negative effect on glucose uptake and growth rates. 
In this study, ΔpfkA mutants also showed no CCR and 
employed xylose co-consumption to increase its growth 
rate. ΔpfkA caused an increased pool size of G6P that 
may have inhibited PTS and decreased biomass accumu-
lation [36, 37].
Gluconeogenesis is usually inactive under high glucose 
concentrations as it is regulated by phosphofructoki-
nase and pyruvate kinase. The lack of EMPP flux could 
facilitate gluconeogenesis for utilization of non-sugar 
based substrates. This is seen in R. opacus, which lacks 
pfk activity and shows simultaneous gluconeogenesis 
and EDP for sugar and phenol co-utilization [13]. In 
this study, ΔpfkA mutants actively utilized acetate from 
the glucose medium. This observation is encouraging 
since acetate is a notorious inhibitor in E. coli cultiva-
tion, because acetate can freely diffuse through the cell 
membrane and disrupt the intracellular pH [21, 38, 39]. 
Fig. 4 Dynamics labeling of central metabolites. Labeling dynamics in selected metabolites postpulse of 13C6-glucose into a Wild Type and  
b WH04. c Relative metabolite peak ratio of central metabolites in WT and ED mutant strains. The glycolysis key node (3PG) is used as the base of 
comparison. d Ratio of WT pool size to mutant pool size for G6P, 6PG, and MAL. The metabolite pools in two mutants, ∆pfkA (JW3887) and WH04, 
were measured via isotopomer ratio analysis. Asterisk 6PG measurement for WT was below detection
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13C-labeling analysis of Asp and Glu revealed that both 
JW3887 and WH04 actively employed the TCA cycle to 
degrade 13C-acetate in the presence of glucose. However, 
increased EDP flux in WH04 repressed the gluconeo-
genesis activity, since EDP overexpression drives high 
flux toward the lower portion of the EMPP.
Despite being more thermodynamically favorable and 
requiring  ~5-fold less enzymatic protein [3], the E. coli 
mutants grew slower than WT after overexpression of 
EDP genes. One reason could be the lower ATP yield of 
EDP as compared to EMPP (this explanation is question-
able since respiration remains the main ATP production 
route in all aerobic cultures via our FBA simulations). 
Another explanation is metabolite channeling. The intra-
cellular environment contains high amounts of macro-
molecules (30–60 % of cell volume) creating a crowding 
effect within the cell that can reduce metabolite diffusion, 
and thus, channeling is an important mechanism for 
in  vivo enzyme reactions [40]. Channeling can be natu-
rally accomplished in the cell via electrostatic interac-
tions, intramolecular tunnels, and small spatial distances 
between enzymes [41]. In eukaryotic cells, channeling is 
present for the TCA cycle and other pathways, as eukary-
otes have organized their pathways within organelles [25, 
26]. Pathways in E. coli have also been found to demon-
strate forms of channeling, such as for fatty acid type II 
synthesis pathway [42]. As shown in this study and previ-
ous studies [43], E. coli EMPP channeling would signifi-
cantly improve reaction thermodynamics and overcome 
kinetic obstacles. Thereby, it could be an important factor 
in WT and WH03 preference for EMPP rather than the 
EDP route.
The channeling process is difficult to study non-inva-
sively, particularly in the central metabolism. In an early 
study by Shearer et al., E. coli was engineered so that the 
mutants could uptake both 14C-glucose and unlabeled 
sugar phosphates [14]. The authors found that the pres-
ence of unlabeled FBP in the culture medium did not 
dilute 14C EMPP intermediates or 14CO2, indicating a 
high degree of EMPP channeling. In this study, we per-
formed 13C-pulse experiments to measure the labeling 
dynamics in WT and the ΔpfkA mutants (Additional files 
2, 3, 4: Figure S2–S4). Our results supported the hypothe-
sis that metabolites are not equilibrated in the cytoplasm 
(Fig. 5a, b). Previous 13C-pulse studies also examined the 
labeling dynamics for wild-type E. coli and B. subtilis, but 
the metabolites reached isotopic steady state within sec-
onds of 13C-pulse [44, 45]. In this study, ΔpfkA mutants 
had slower metabolite transfer rates, and accumulated 
the upstream hexose6Ps outside of the channel (Fig. 5b). 
The resulting presence of two pools of the same metabo-
lite allowed 13C-pulse experiments to detect unsequential 
metabolite labeling through glycolysis.
Channeling may have several implications on our 
understanding of cell physiology. First, metabolite chan-
neling avoids diffusion limitations and thus significantly 
improves bioconversion efficiency [41]. Channeling 
would explain the robustness of natively evolved path-
ways for biosynthesis, encouraging synthetic biologists 
to replicate channeling as a strategy to improve heter-
ologous pathway efficiency (e.g., colocalization/compart-
mentalization of overexpressed enzymes) [46]. Second, it 
necessitates that we rethink the in vivo Gibbs free energy 
or kinetics typically reported in studies, since the global 
metabolite pool measurement does not reflect the local 
substrate concentrations (The notion of ‘one perfectly 
mixed solution’ may be a poor reflection of the cell ‘in 
vivo’). This presents complications with metabolic mod-
eling. Third, metabolite channeling could affect steady-
state 13C-metabolic flux analysis, because channeling 
may prevent the carbon randomization during conver-
sion of a symmetric metabolite or introduce bypass 
routes for 13C labeling [24]. Finally, we hypothesize that 
channeling could be another factor behind CCR. At 
high growth rates, the EMPP is capable of reaching fast 
Fig. 5 Schemes of hypothesized channeling and its influence on 
catabolite repression. An enzymatic pathway of sequential metabo-
lites W, X, Y, and Z forms a channel. Delta represents the presence of a 
bottleneck that limits flux through the channel. a In a fully channeled 
network, most substrates exist within the channel with few substrates 
existing in cytosol. The pulse of 13C (asterisk) into the channeled 
pathway results in sequential and fast labeling of metabolites W, X, Y, 
and Z. b In a fractured channel, a disturbance in an enzyme (X→Y) 
causes accumulation of X in the cytosol, which is metabolically less 
active. After the pulse of 13C (asterisk), the labeling of bulk X* will be 
diluted by unlabeled Xo in the cytosol during LC–MS analysis. The 
downstream metabolites Y and Z may show faster 13C-labeling if 
their unlabeled pools in cytosol are small. In this case, the pulse of 13C 
and measurement of metabolite labeling dynamics can capture the 
features of channeling. c Substrate channeling can be another factor 
leading to CCR. The presence of channeling favors fast W conver-
sion through the channeled pathway, while diffusion of cytosol 
metabolite (X) from secondary substrate (U) into channeled pathway 
becomes limited. d Catabolite repression is reduced if the channeled 
pathway flux is downregulated, allowing for cytosol X to diffuse into 
the channeled pathway
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Fig. 6 FBA of ΔpfkA (JW3887) and WH04. The FBA was constrained by the 13C-flux ratio and optimized for biomass accumulation. a Heat Map 
of the difference (Fluxmutant-FluxWT) in the optimal fluxes (normalized to total carbon uptake rate, which was set to one) between mutant strains 
(ΔpfkA-JW3887 and WH04) and WT (green showed increased relative flux compared to wild type, red showed decreased relative flux compared to 
wild type). b Absolute total productions of ATP, NADH, and NADPH. c Simulated and measured growth rates of the different strains and growth 
conditions. The wild-type strain glucose uptake rate was assumed to be 8.5 mmol/h/g DCW
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glucose catabolic rates, such that metabolites derived 
from other substrates (e.g., xylose) cannot sufficiently 
diffuse into the EMPP channel (i.e., glucose catabolite 
repression). During slow growth conditions, glucose cat-
abolic flux decreases. This favors diffusion of metabolites 
from cytosol into the EMPP channel and encourage the 
coutilization of the secondary substrate (Fig.  5c, d). In 
reality, inhibition of EMPP flux (e.g., removal of glucose 
transporter ΔptsG or glucose-limiting  chemostat cul-
tures) allows E. coli to cometabolize glycerol with glucose 
[47].
Conclusion
We have rewired the E. coli central metabolic network 
through a pfkA knockout and EDP overexpression. The 
altered strains alleviated glucose catabolite repression, 
and could be beneficial in biosynthesis from renewable 
cellulosic hydrolysates. Physiological analyses of differ-
ent glycolytic strategy clearly revealed that despite the 
theoretical prediction that EDP could be a preferred 
glycolysis pathway based on both thermodynamics and 
the cost of enzymatic protein, the cell prefers EMPP for 
optimal growth. The results of 13C-pulse experiment 
revealed a form of glycolysis channeling that, if proven, 
could significantly affect our understanding of reaction 
thermodynamics, flux analysis, and synthetic biology 
applications.
Methods
Chemicals
Glucose, [1-13C] glucose, [U-13C] glucose, [U-13C] ace-
tate, and all other chemicals unless otherwise stated 
were purchased from Sigma Aldrich (St. Louis, MO). Q5 
High Fidelity 2X Master Mix was obtained from New 
England Biolabs (Ipswich, MA), and all other enzymes 
were purchased through Thermo Scientific (Waltham, 
MA).
Construction of strains and plasmids
All plasmids were developed from a BglBrick expres-
sion vector, pBbE5c-YFP, which contains a ColE1 origin 
of replication, chloramphenicol resistance and LacUV5 
promoter [48]. The genes, phosphogluconate dehydratase 
(edd) and 2-dehydro-3-deoxyphosphogluconate aldolase 
(eda) were PCR-amplified from genomic DNA of E. coli 
K-12 MG1655. The plasmid pEDW was assembled from 
the PCR-amplified genomic region from edd to eda into 
pBbE5c backbone via Gibson assembly. Primers used for 
plasmid construction are the following:
eddeda01_fwd: CTTTTAAGAAGGAGATATACATA 
TGAATCCACAATTGTTACGCG.
eddeda01_rev: CGAGTTTGGATCCTTACAGCTT 
AGCGCCTTCTACAGC.
vecbac01_fwd: GGCGCTAAGCTGTAAGGATCCAA 
ACTCGAGTAAGGATCTCC.
vecbac01_rev: CGCGTAACAATTGTGGATTCATA 
TGTATATCTCCTTCTTAAAAGATCTTTTGAATTC.
Table  1 lists the resulting mutant strains, their JBEI 
ICE registry numbers, and growth rates. All strains gen-
erated at JBEI are available thought the JBEI Registry 
(https://acs-registry.jbei.org; [49]). The plasmid was first 
transformed into DH10B for plasmid propagation, and 
then verified by sequencing completed by Quintara (San 
Francisco, CA). After verification for no mutations, the 
plasmid was transformed into Keio collection strains, 
BW25113 (WT) and the ∆pfkA mutant (JW3887) [15], 
obtained from the Yale E. coli Genetic Stock Center (New 
Haven, CT).
Media composition and growth conditions
Seed cultures were grown in LB for  ~12  h, then inocu-
lated (2 % v/v) in M9 minimal medium overnight. Strains 
were then inoculated in fresh M9 minimal medium (~2 % 
v/v). The M9 medium (pH = 7–7.5) consisted of 11 g/L 
of 5× M9 salts (Sigma Aldrich, St. Louis, MO), 2  mM 
MgSO4·7H2O, 0.1 mM CaCl2·2H2O, 1 mg/L of Thiamine 
HCl, 3  mg/L of FeSO4·7H2O, and trace minerals. Initial 
sugar concentrations were 10  g/L of glucose and 6  g/L 
of xylose. For mutant cultures, 30  mg/L chlorampheni-
col and 10  mg/L kanamycin were supplied as needed. 
50  µM Isopropyl β-d-1-thiogalactopyranoside (IPTG) 
was used to induce plasmid borne genes at early expo-
nential growth phase. To study acetate coutilization, 
6 g/L sodium acetate (or 6 g/L NaCl served as a control) 
was added at early phase of mutant cultures (OD600 ~ 0.2, 
pH ~ 7.5) with the IPTG induction. All cultivations were 
aerobic and conducted in 5 mL cultures in test tubes on 
a rotary shaker at 250 rpm at 37 °C. For labeling experi-
ments, unlabeled glucose was replaced with 100 % [1-13C] 
glucose or 100 % [U-13C] glucose, and unlabeled acetate 
was replaced with [U-13C] acetate.
13C‑pulse experiments
Strains were grown in approximately 70  mL cultures in 
250-mL Erlenmeyer flasks on a rotary shaker at 250 rpm 
with 2 g/L unlabeled glucose M9 media. In all 13C-pulse 
experiments, cultures in exponential growth phase 
(pH  =  6–7) were pulsed with 5  mL–60  g/L 13C6-glu-
cose stock solution. To measure the 13C-incorporation 
into glycolysis metabolites over time, cultures were har-
vested at different time points (from 15 s to 3 min). The 
harvested samples were quenched using the procedure 
of Fast-Cooling [50]. Specifically,  ~10  mL culture was 
poured into a 50-mL falcon tube containing 2  mL ice-
cold M9 medium (no carbon source) and the tube was 
immediately immersed in liquid N2. To facilitate heat 
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transfer and avoid ice formation in the sample solution 
during the liquid N2 bath, the sample solutions were 
manually agitated using a digital thermometer. The sam-
ple solution could be cooled to 0 °C in 10 s. The ice-cold 
samples were centrifuged at 0 °C for 3 min, and the pel-
lets were stored at −80 °C until metabolite extraction.
Sugar measurement
Supernatant samples were taken in parallel experiments 
separate from cultures used for optical density measure-
ment to reduce the loss of volume. At each time point, at 
least 150 µL of culture was extracted, centrifuged to remove 
cell biomass, and stored at −20  °C. Samples were diluted 
by 2× and then filtered through 0.22 μm centrifugal filters. 
Samples were run on an Agilent Technologies 1200 series 
HPLC equipped with an Aminex H column, and the con-
centrations were estimated based on standard curves [51].
Amino acid extraction and GC–MS analysis
Amino acid extraction and GC–MS analysis were per-
formed as described previously [52]. Briefly, cell pellets 
from 5  mL cultures taken during the exponential phase 
were washed with 0.9 % (w/v) of NaCl solution, and then 
hydrolyzed in 6  M HCl at 100  °C. The resulting amino 
acids were derivatized by N-tert-butyldimethylsilyl-
N-methyltrifluoroacetamide prior to GC–MS analysis. 
For isotopic tracing, we used the fragments [M-15]+ or 
[M-57]+ (containing the entire amino acid backbone) and 
[M-159]+ or [M-85]+ (containing the amino acid back-
bone after loss of its first carbon). The natural isotopic 
abundance of derivatized amino acids was corrected 
using a reported algorithm [53]. The mass isotopomer 
distributions of alanine and serine for the strains used are 
given in Additional file 5: Table S1.
1-13C glucose was used to measure in  vivo glucose 
catabolism: the OPPP cleaves the labeled carbon as CO2; 
the EDP produces the first carbon labeled pyruvate, while 
EMPP results in the labeled carbon present in the third 
position of pyruvate [1]. GC–MS analysis of alanine 
(synthesized from pyruvate) can reveal this positional 
labeling as further described previously [8, 13, 54]. Equa-
tions  (1–3) were solved for estimation of the flux ratios 
between the three pathways (without considering metab-
olite channeling effect):
(1)Ala100 =
vEDP
2vEDP + 2vEMPP +
5
3
vOPPP
,
(2)Ala000 =
5
3
vOPPP + vEDP + vEMPP
2vEDP + 2vEMPP +
5
3
vOPPP
,
(3)
Ala001 =
vEMPP
2vEDP + 2vEMPP +
5
3
vOPPP
,
where vEDP, vEMPP, and vOPPP are the estimated fluxes for 
the EDP, EMPP, and OPPP, respectively. Alaxxx are the 
fractions of the isotopomer determined by fragmentation 
data, with 1 denoting a 13Carbon isotope. For example, 
Ala100 is the fraction of alanine labeled at carbon position 
1, a unique isotopomer produced by the EDP. The calcu-
lated flux ratios are estimations, which assume the reac-
tions are irreversible.
Metabolite extraction and LC–MS/MS analysis
After quenching, the cell pellet was suspended in 1 mL of 
cooled 7:3 methanol:chloroform mixture. These samples 
were then placed on a rotary shaker at 250 rpm, overnight 
at 4 °C. The methanol layer was separated with the addi-
tion of 500 µL of water, then filtered through an Amicon 
Ultra centrifuge filter (3000 Da; EMD Millipore, Billerica, 
MA), lyophilized (−50  °C) and reconstituted in 100  µL 
of acetonitrile–water (6:4, v/v). The samples were then 
analyzed via liquid chromatography-mass spectrometry 
(LC–MS) using a SeQuant Zic-pHILIC column (EMD 
Millipore, Billerica, MA, USA) in an Agilent Technologies 
1200 Series HPLC system. The mobile phase was com-
posed of 15  mM ammonium carbonate (Sigma-Aldrich, 
St. Louis, MO, USA) in water (solvent A) and 15  mM 
ammonium carbonate in 75 % acetonitrile and 25 % water 
(solvent B). A flow rate of 0.2  mL/min was used, unless 
stated otherwise. Metabolites were separated via gradient 
elution under the following conditions: 100 % B (0 min), 
82 % B (4.4 min), 72 % B (7.7 min), 60 % B (9.7 min), 100 % 
B (10.2 min), 100 % B (12.5 min), 100 % B (13 min, 0.4 mL/
min), and 100 % B (18.5 min, 0.4 mL/min). The HPLC sys-
tem was coupled to an Agilent Technologies 6210 series 
time-of-flight mass spectrometer (for LC–TOF MS) 
via a MassHunter workstation (Agilent Technologies, 
USA). A split ratio of 1:4 was used throughout. Drying 
and nebulizing gases were set to 10 L/min and 25 lb/in.2, 
respectively, and a drying-gas temperature of 300 °C was 
used throughout. Electrospray ionization (ESI) was con-
ducted in the negative ion mode and a capillary voltage 
of 3500 V was utilized. The acquisition range was from 70 
to 1000 m/z, and the acquisition rate was 0.86 spectra/s. 
Metabolite mass isotopomer distribution was determined 
based on the ratio of the integrated peak area of the cho-
sen isotopomer to the sum of all the integrated peak areas 
of the possible isotopomers for the given metabolite.
Estimation of pool size via isotope‑ratio approach
The relative pool size of key metabolites (G6P, 6PG, and 
3PG) was measured via an isotope-based ratio approach, 
as modified from [55]. Wild-type (BW25113) was culti-
vated in 5  g/L of 13C6-glucose and 1  g/L of fully labeled 
13C-sodium bicarbonate, which generated 13C-metabo-
lites as internal standards. The fully labeled WT biomass 
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and the unlabeled mutant cultures were quenched using 
liquid N2 as described earlier, then mixed together at 1:1 
volume ratio for metabolite extraction. The ratio of WT 
metabolite pool size (labeled peak area) to the mutant 
strains metabolite pool size (unlabeled peak area) was 
determined using LC–MS, which provided a qualitative 
comparison of metabolite pool sizes between WT and 
mutants.
Flux balance analysis constrained by measured flux ratios
The E. coli Genome Scale Model iJO1366 (2251 meta-
bolic reactions) was adapted for metabolic modeling 
of mutants under the different growth conditions [56]. 
Flux balance analysis (FBA) used the following objective 
function:
Maximize µ
Subject to: S · v = 0 
where S represents the stoichiometric matrix, v rep-
resents the matrix of reaction rates (fluxes), while 
matrices lb and ub are the lower and upper bounds, 
respectively. Glucose, xylose, and acetate uptake rates 
were fixed to measured average values  with 5  % pre-
sumed variation. Flux ratios determined by 13C-analysis 
were used to constrain fluxes through EMPP, EDP, and 
OPPP (Fig.  1). As the activities of pfkA and pfkB were 
lumped in iJO1366, the PFK reaction was not con-
strained. All generated fluxes were normalized to total 
substrate uptake rate.
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